肺纤维化 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "肺纤维化" in Chinese language version.

refsWebsite

Global rank Chinese rank

17web.archive.org

1^st place

10nih.gov

4^th place

5^th place

8doi.org

2^nd place

23^rd place

7mayoclinic.org

1,610^th place

2,275^th place

1medlineplus.gov

1,581^st place

1,717^th place

1medicinenet.com

3,840^th place

2,560^th place

1worldcat.org

5^th place

12^th place

1thoracic.org

low place

1bidmc.org

low place

1medscape.com

719^th place

889^th place

1spirxpert.com

low place

1uq.edu.au

3,558^th place

2,972^nd place

1unisi.it

low place

bidmc.org

Not Found - BIDMC. bidmc.org. [29 April 2018]. （原始内容存档于16 March 2014）.

doi.org

Ahmad Alhiyari, Mousa; Ata, Fateen; Islam Alghizzawi, Mohd; Bint I Bilal, Ammara; Salih Abdulhadi, Ahmad; Yousaf, Zohaib. Post COVID-19 fibrosis, an emerging complicationof SARS-CoV-2 infection. IDCases. 2020-12-31, 23: e01041. ISSN 2214-2509. PMC 7785952 . PMID 33425682. doi:10.1016/j.idcr.2020.e01041.
Risk of cryptogenic fibrosing alveolitis in metal workers.. Lancet. 2000, 355 (9202): 466–467. PMID 10841131. doi:10.1016/S0140-6736(00)82017-6.
Nitrofurantoin-induced pulmonary fibrosis: a case report. J Med Case Rep. 2008, 2: 169. PMC 2408600 . PMID 18495029. doi:10.1186/1752-1947-2-169.
Idiopathic pulmonary fibrosis. N Engl J Med. 2001, 345 (7): 517–525. PMC 2231521 . PMID 16928146. doi:10.1056/NEJMra003200.
Improved pulmonary function in chronic quadriplegics after pulmonary therapy and arm ergometry. Paraplegia. August 1989, 27 (4): 278–83. PMID 2780083. doi:10.1038/sc.1989.42.
King TE Jr; Bradford WZ; Castro-Bernardini S; et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. (PDF). NEJM. May 2014, 370 (22): 2083–2092 [2022-03-03]. PMID 24836312. doi:10.1056/NEJMoa1402582. （原始内容 (PDF)存档于2021-12-19）.
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med. 2011, 365 (12): 1079–1087. PMID 21992121. doi:10.1056/nejmoa1103690.
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis (PDF). N Engl J Med. May 2014, 370 (22): 2071–2082 [2022-03-03]. PMID 24836310. doi:10.1056/NEJMoa1402584. （原始内容 (PDF)存档于2021-08-28）.

mayoclinic.org

Pulmonary fibrosis - Symptoms and causes. Mayo Clinic. [20 December 2019]. （原始内容存档于2014-07-15）（英语）.
Pulmonary fibrosis - Diagnosis and treatment - Mayo Clinic. www.mayoclinic.org. [20 December 2019]. （原始内容存档于2014-07-04）.
Mayo Clinic Staff. Symptoms. Mayo Clinic (Mayo Foundation for Medical Education and Research). [26 July 2014]. （原始内容存档于4 July 2014）.
Mayo Clinic Staff. Causes. Mayo Foundation for Medical Education and Research. [26 July 2014]. （原始内容存档于1 October 2014）.
Mayo Clinic Staff. Complications. Mayo Foundation for Medical Education and Research. [26 July 2014]. （原始内容存档于4 July 2014）.
Mayo Clinic Staff. Tests and diagnosis. Mayo Foundation for Medical Education and Research. [26 July 2014]. （原始内容存档于4 July 2014）.
Mayo Clinic Staff. Lifestyle and home remedies. Mayo Foundation for Medical Education and Research. [26 July 2014]. （原始内容存档于4 July 2014）.

medicinenet.com

Pulmonary Fibrosis. MedicineNet, Inc. [26 July 2014]. （原始内容存档于19 July 2014）.

medlineplus.gov

Pulmonary Fibrosis. medlineplus.gov. [20 December 2019]. （原始内容存档于2016-07-05）. 引用错误：带有name属性“NIH2019”的<ref>标签用不同内容定义了多次

medscape.com

emedicine.medscape.com

eMedicine Specialties > Pulmonology > Interstitial Lung Diseases > Restrictive Lung Disease 互联网档案馆的存檔，存档日期5 March 2010. Author: Lalit K Kanaparthi, MD, Klaus-Dieter Lessnau, MD, Sat Sharma, MD. Updated: 27 July 2009

nih.gov

ncbi.nlm.nih.gov

Ahmad Alhiyari, Mousa; Ata, Fateen; Islam Alghizzawi, Mohd; Bint I Bilal, Ammara; Salih Abdulhadi, Ahmad; Yousaf, Zohaib. Post COVID-19 fibrosis, an emerging complicationof SARS-CoV-2 infection. IDCases. 2020-12-31, 23: e01041. ISSN 2214-2509. PMC 7785952 . PMID 33425682. doi:10.1016/j.idcr.2020.e01041.
Risk of cryptogenic fibrosing alveolitis in metal workers.. Lancet. 2000, 355 (9202): 466–467. PMID 10841131. doi:10.1016/S0140-6736(00)82017-6.
Nitrofurantoin-induced pulmonary fibrosis: a case report. J Med Case Rep. 2008, 2: 169. PMC 2408600 . PMID 18495029. doi:10.1186/1752-1947-2-169.
Idiopathic pulmonary fibrosis. N Engl J Med. 2001, 345 (7): 517–525. PMC 2231521 . PMID 16928146. doi:10.1056/NEJMra003200.
Improved pulmonary function in chronic quadriplegics after pulmonary therapy and arm ergometry. Paraplegia. August 1989, 27 (4): 278–83. PMID 2780083. doi:10.1038/sc.1989.42.
King TE Jr; Bradford WZ; Castro-Bernardini S; et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. (PDF). NEJM. May 2014, 370 (22): 2083–2092 [2022-03-03]. PMID 24836312. doi:10.1056/NEJMoa1402582. （原始内容 (PDF)存档于2021-12-19）.
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med. 2011, 365 (12): 1079–1087. PMID 21992121. doi:10.1056/nejmoa1103690.
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis (PDF). N Engl J Med. May 2014, 370 (22): 2071–2082 [2022-03-03]. PMID 24836310. doi:10.1056/NEJMoa1402584. （原始内容 (PDF)存档于2021-08-28）.

nlm.nih.gov

MedlinePlus > Pulmonary Fibrosis 互联网档案馆的存檔，存档日期5 July 2016. Date last updated: 9 February 2010

ghr.nlm.nih.gov

Idiopathic pulmonary fibrosis. Genetics Home Reference, United States National Library of Medicine. [2022-03-03]. （原始内容存档于2018-09-26）.

spirxpert.com

www.spirXpert.com. （原始内容存档于28 January 2010）.

thoracic.org

American Thoracic Society - General Information about Pulmonary Fibrosis. www.thoracic.org. [20 December 2019]. （原始内容存档于2019-12-20）.

unisi.it

usiena-air.unisi.it

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis (PDF). N Engl J Med. May 2014, 370 (22): 2071–2082 [2022-03-03]. PMID 24836310. doi:10.1056/NEJMoa1402584. （原始内容 (PDF)存档于2021-08-28）.

uq.edu.au

espace.library.uq.edu.au

King TE Jr; Bradford WZ; Castro-Bernardini S; et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. (PDF). NEJM. May 2014, 370 (22): 2083–2092 [2022-03-03]. PMID 24836312. doi:10.1056/NEJMoa1402582. （原始内容 (PDF)存档于2021-12-19）.

web.archive.org

Pulmonary Fibrosis. medlineplus.gov. [20 December 2019]. （原始内容存档于2016-07-05）. 引用错误：带有name属性“NIH2019”的<ref>标签用不同内容定义了多次
Pulmonary fibrosis - Symptoms and causes. Mayo Clinic. [20 December 2019]. （原始内容存档于2014-07-15）（英语）.
Pulmonary Fibrosis. MedicineNet, Inc. [26 July 2014]. （原始内容存档于19 July 2014）.
Pulmonary fibrosis - Diagnosis and treatment - Mayo Clinic. www.mayoclinic.org. [20 December 2019]. （原始内容存档于2014-07-04）.
American Thoracic Society - General Information about Pulmonary Fibrosis. www.thoracic.org. [20 December 2019]. （原始内容存档于2019-12-20）.
Mayo Clinic Staff. Symptoms. Mayo Clinic (Mayo Foundation for Medical Education and Research). [26 July 2014]. （原始内容存档于4 July 2014）.
MedlinePlus > Pulmonary Fibrosis 互联网档案馆的存檔，存档日期5 July 2016. Date last updated: 9 February 2010
Mayo Clinic Staff. Causes. Mayo Foundation for Medical Education and Research. [26 July 2014]. （原始内容存档于1 October 2014）.
Idiopathic pulmonary fibrosis. Genetics Home Reference, United States National Library of Medicine. [2022-03-03]. （原始内容存档于2018-09-26）.
Not Found - BIDMC. bidmc.org. [29 April 2018]. （原始内容存档于16 March 2014）.
Mayo Clinic Staff. Complications. Mayo Foundation for Medical Education and Research. [26 July 2014]. （原始内容存档于4 July 2014）.
eMedicine Specialties > Pulmonology > Interstitial Lung Diseases > Restrictive Lung Disease 互联网档案馆的存檔，存档日期5 March 2010. Author: Lalit K Kanaparthi, MD, Klaus-Dieter Lessnau, MD, Sat Sharma, MD. Updated: 27 July 2009
Mayo Clinic Staff. Tests and diagnosis. Mayo Foundation for Medical Education and Research. [26 July 2014]. （原始内容存档于4 July 2014）.
www.spirXpert.com. （原始内容存档于28 January 2010）.
King TE Jr; Bradford WZ; Castro-Bernardini S; et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. (PDF). NEJM. May 2014, 370 (22): 2083–2092 [2022-03-03]. PMID 24836312. doi:10.1056/NEJMoa1402582. （原始内容 (PDF)存档于2021-12-19）.
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis (PDF). N Engl J Med. May 2014, 370 (22): 2071–2082 [2022-03-03]. PMID 24836310. doi:10.1056/NEJMoa1402584. （原始内容 (PDF)存档于2021-08-28）.
Mayo Clinic Staff. Lifestyle and home remedies. Mayo Foundation for Medical Education and Research. [26 July 2014]. （原始内容存档于4 July 2014）.

worldcat.org

Ahmad Alhiyari, Mousa; Ata, Fateen; Islam Alghizzawi, Mohd; Bint I Bilal, Ammara; Salih Abdulhadi, Ahmad; Yousaf, Zohaib. Post COVID-19 fibrosis, an emerging complicationof SARS-CoV-2 infection. IDCases. 2020-12-31, 23: e01041. ISSN 2214-2509. PMC 7785952 . PMID 33425682. doi:10.1016/j.idcr.2020.e01041.